EXCELLTHERA

Serial Number 88167461
Registration 6639560
700

Registration Progress

Application Filed
Oct 24, 2018
Under Examination
Jun 18, 2019
Approved for Publication
Apr 23, 2019
Published for Opposition
Apr 23, 2019
Registered
Feb 8, 2022

Trademark Image

EXCELLTHERA

Basic Information

Serial Number
88167461
Registration Number
6639560
Filing Date
October 24, 2018
Registration Date
February 8, 2022
Published for Opposition
April 23, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 8, 2022
Registration
Registered
Classes
005 042

Rights Holder

ExcellThera Inc.

03
Address
2950 Chemin de Polytechnique
Montreal, Quebec H3T1J4
CA

Ownership History

ExcellThera Inc.

Original Applicant
03
Montreal, Quebec CA

ExcellThera Inc.

Owner at Publication
03
Montreal, Quebec CA

ExcellThera Inc.

Original Registrant
03
Montreal, Quebec CA

Legal Representation

Attorney
Ernest V. Linek

USPTO Deadlines

Next Deadline
918 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-02-08)
Due Date
February 08, 2028
Grace Period Ends
August 08, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

38 events
Date Code Type Description Documents
Feb 8, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 5, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jan 4, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jan 4, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jan 4, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 10, 2021 IUAF S USE AMENDMENT FILED Loading...
Dec 10, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jun 3, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 1, 2021 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jun 1, 2021 EXT4 S SOU EXTENSION 4 FILED Loading...
Jun 1, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 25, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 23, 2020 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 23, 2020 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 23, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 16, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 14, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 14, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
May 14, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 18, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 16, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 16, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 16, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 18, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 23, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 23, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 3, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 19, 2019 FIXD O ELECTRONIC RECORD REVIEW COMPLETE Loading...
Mar 15, 2019 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Loading...
Mar 4, 2019 ALIE A ASSIGNED TO LIE Loading...
Feb 13, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 13, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 13, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 13, 2019 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Feb 13, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 31, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 6, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 27, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations in the nature of stem cells solutions to enable stem cell expansion for therapeutic purposes, used in hematopoietic stem cell transplantation (HSCT) for patients with blood cancers; Bioengineering pharmaceutical solutions containing small molecules for use in expanding cells for therapeutic use to patients with blood cancers and other diseases
First Use Anywhere: Jun 25, 2021
First Use in Commerce: Jun 25, 2021
Class 042
Medical and scientific research in the field of stem cells; medical laboratory research; medical and scientific research, namely, conducting pre-clinical and clinical trials for others
First Use Anywhere: Jun 25, 2021
First Use in Commerce: Jun 25, 2021

Classification

International Classes
005 042